Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology

Srinath Adusumalli; Jose Alvarez-Cardona; Sameed M. Khatana; Joshua D. Mitchell; Anne H. Blaes; Stephen J. Casselli; Rupal O’Quinn; Daniel J. Lenihan

doi:10.1007/s12265-020-10010-x

Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology

Srinath Adusumalli, Jose Alvarez-Cardona, Sameed M. Khatana, Joshua D. Mitchell, Anne H. Blaes, Stephen J. Casselli, Rupal O’Quinn, Daniel J. Lenihan

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

The burgeoning field of cardio-oncology (C-O) is now necessary for the delivery of excellent care for patients with cancer. Many factors have contributed to this increasing population of cancer survivors or those being treated with novel and targeted cancer therapies. There is a tremendous need to provide outstanding cardiovascular (CV) care for these patients; however, current medical literature actually provides a paucity of guidance. C-O therefore provides a novel opportunity for clinical, translational, and basic research to advance patient care. This review aims to be a primer for cardio-oncologists on how to develop a vibrant and comprehensive C-O program, use practical tools to assist in the construction of C-O services, and to proactively incorporate translational and clinical research into the training of future leaders as well as enhance clinical care.

Original language	English (US)
Pages (from-to)	495-505
Number of pages	11
Journal	Journal of cardiovascular translational research
Volume	13
Issue number	3
DOIs	https://doi.org/10.1007/s12265-020-10010-x
State	Published - Jun 1 2020

Bibliographical note

Funding Information:
The authors report no relevant conflicts for this manuscript with the exception of DL who has received research funding from Myocardial Solutions, Inc. and has modest consultant arrangements with Roche, Bristol-Myers Squibb, and Pfizer.

Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.

Keywords

Cardio-oncology
Practice excellence
Program development
Translational research

PubMed: MeSH publication types

Journal Article
Review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1007/s12265-020-10010-x

OpenUrl availability

Full text

Cite this

Adusumalli, S., Alvarez-Cardona, J., Khatana, S. M., Mitchell, J. D., Blaes, A. H., Casselli, S. J., O’Quinn, R., & Lenihan, D. J. (2020). Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology. Journal of cardiovascular translational research, 13(3), 495-505. https://doi.org/10.1007/s12265-020-10010-x

Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology. / Adusumalli, Srinath; Alvarez-Cardona, Jose; Khatana, Sameed M. et al.
In: Journal of cardiovascular translational research, Vol. 13, No. 3, 01.06.2020, p. 495-505.

Research output: Contribution to journal › Review article › peer-review

Adusumalli, S, Alvarez-Cardona, J, Khatana, SM, Mitchell, JD, Blaes, AH, Casselli, SJ, O’Quinn, R & Lenihan, DJ 2020, 'Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology', Journal of cardiovascular translational research, vol. 13, no. 3, pp. 495-505. https://doi.org/10.1007/s12265-020-10010-x

@article{2a287f36c67d411ab61b8c6766a4c4db,

title = "Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology",

abstract = "The burgeoning field of cardio-oncology (C-O) is now necessary for the delivery of excellent care for patients with cancer. Many factors have contributed to this increasing population of cancer survivors or those being treated with novel and targeted cancer therapies. There is a tremendous need to provide outstanding cardiovascular (CV) care for these patients; however, current medical literature actually provides a paucity of guidance. C-O therefore provides a novel opportunity for clinical, translational, and basic research to advance patient care. This review aims to be a primer for cardio-oncologists on how to develop a vibrant and comprehensive C-O program, use practical tools to assist in the construction of C-O services, and to proactively incorporate translational and clinical research into the training of future leaders as well as enhance clinical care.",

keywords = "Cardio-oncology, Practice excellence, Program development, Translational research",

author = "Srinath Adusumalli and Jose Alvarez-Cardona and Khatana, {Sameed M.} and Mitchell, {Joshua D.} and Blaes, {Anne H.} and Casselli, {Stephen J.} and Rupal O{\textquoteright}Quinn and Lenihan, {Daniel J.}",

note = "Funding Information: The authors report no relevant conflicts for this manuscript with the exception of DL who has received research funding from Myocardial Solutions, Inc. and has modest consultant arrangements with Roche, Bristol-Myers Squibb, and Pfizer. Publisher Copyright: {\textcopyright} 2020, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2020",

month = jun,

day = "1",

doi = "10.1007/s12265-020-10010-x",

language = "English (US)",

volume = "13",

pages = "495--505",

journal = "Journal of cardiovascular translational research",

issn = "1937-5387",

publisher = "Springer New York",

number = "3",

}

TY - JOUR

T1 - Clinical Practice and Research in Cardio-Oncology

T2 - Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology

AU - Adusumalli, Srinath

AU - Alvarez-Cardona, Jose

AU - Khatana, Sameed M.

AU - Mitchell, Joshua D.

AU - Blaes, Anne H.

AU - Casselli, Stephen J.

AU - O’Quinn, Rupal

AU - Lenihan, Daniel J.

N1 - Funding Information: The authors report no relevant conflicts for this manuscript with the exception of DL who has received research funding from Myocardial Solutions, Inc. and has modest consultant arrangements with Roche, Bristol-Myers Squibb, and Pfizer. Publisher Copyright: © 2020, Springer Science+Business Media, LLC, part of Springer Nature.

PY - 2020/6/1

Y1 - 2020/6/1

N2 - The burgeoning field of cardio-oncology (C-O) is now necessary for the delivery of excellent care for patients with cancer. Many factors have contributed to this increasing population of cancer survivors or those being treated with novel and targeted cancer therapies. There is a tremendous need to provide outstanding cardiovascular (CV) care for these patients; however, current medical literature actually provides a paucity of guidance. C-O therefore provides a novel opportunity for clinical, translational, and basic research to advance patient care. This review aims to be a primer for cardio-oncologists on how to develop a vibrant and comprehensive C-O program, use practical tools to assist in the construction of C-O services, and to proactively incorporate translational and clinical research into the training of future leaders as well as enhance clinical care.

AB - The burgeoning field of cardio-oncology (C-O) is now necessary for the delivery of excellent care for patients with cancer. Many factors have contributed to this increasing population of cancer survivors or those being treated with novel and targeted cancer therapies. There is a tremendous need to provide outstanding cardiovascular (CV) care for these patients; however, current medical literature actually provides a paucity of guidance. C-O therefore provides a novel opportunity for clinical, translational, and basic research to advance patient care. This review aims to be a primer for cardio-oncologists on how to develop a vibrant and comprehensive C-O program, use practical tools to assist in the construction of C-O services, and to proactively incorporate translational and clinical research into the training of future leaders as well as enhance clinical care.

KW - Cardio-oncology

KW - Practice excellence

KW - Program development

KW - Translational research

UR - http://www.scopus.com/inward/record.url?scp=85085301739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085301739&partnerID=8YFLogxK

U2 - 10.1007/s12265-020-10010-x

DO - 10.1007/s12265-020-10010-x

M3 - Review article

C2 - 32444945

AN - SCOPUS:85085301739

SN - 1937-5387

VL - 13

SP - 495

EP - 505

JO - Journal of cardiovascular translational research

JF - Journal of cardiovascular translational research

IS - 3

ER -

Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this